Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01647607 · ClinicalTrials.gov registry record · NA

Young and Strong: An Education and Supportive Care Intervention Study for Young Women With Breast Cancer

A NA study, sponsored by Dana-Farber Cancer Institute.

Completed
Registry status
NA
Development phase
467
Enrollment target

NCT01647607: Completed NA study, sponsored by Dana-Farber Cancer Institute.

NCT01647607 is a NA study that has completed, run by Dana-Farber Cancer Institute. The registered enrollment target is 467 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (67% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01647607, a NA study, has completed, sponsored by Dana-Farber Cancer Institute.

COMPLETED
Registry status
NA
Development phase
467 participants
Enrollment target

Study Summary

The purpose of this study is to address gaps in care of young women with breast cancer by determining whether educational interventions focusing on issues unique to young women with breast cancer and healthy lifestyles for women with breast cancer help to improve care of young breast cancer patients. The investigators believe that if addressed early in a young woman's care, concerns related to fertility, body image, sexual dysfunction, and physical activity will improve the satisfaction with care and quality of life of this vulnerable population. The research will be conducted by exporting refined, previously piloted educational interventions to 14 academic sites and 40 community medical clinics. The investigators will compare how interaction with each intervention affects patients' quality of life and satisfaction with quality of care.

Primary Outcome

The YWI and PAI arms will be compared in terms of the attention rate at 3 months using generalized estimated equations (GEEs) to account for clustered binary data. Comparison will be based on testing the term for treatment arm.

Interventions

  • BEHAVIORAL Young Women's Intervention (YWI)
  • BEHAVIORAL Physical Activity Intervention (PAI)

Trial Details

FieldValue
Enrollment Target 467 participants
Start Date 2012-06
Est. Completion 2017-12-20
Phase NA
Dana-Farber Cancer Institute

781 total trials

What the finished NCT01647607 record still lists

NCT01647607 is an interventional study that assigns participants to a tested intervention. The registered 467 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (67% lower).

The record links to 0 conditions, and to 2 interventions - of which Young Women's Intervention (YWI) is the first listed.

NCT01647607 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01647607 about?

NCT01647607 is a clinical study titled "Young and Strong: An Education and Supportive Care Intervention Study for Young Women With Breast Cancer". The purpose of this study is to address gaps in care of young women with breast cancer by determining whether educational interventions focusing on issues unique to young women with breast cancer and healthy lifestyles for women with breast cancer help to improve care of young breast cancer patients...

What is the current status of trial NCT01647607?

This trial is currently completed. It is a NA study. The enrollment target is 467 participants. The study started on 2012-06. Estimated completion is 2017-12-20.

What interventions are being tested in trial NCT01647607?

The interventions under investigation include: Young Women's Intervention (YWI) (BEHAVIORAL), Physical Activity Intervention (PAI) (BEHAVIORAL).

Who is sponsoring clinical trial NCT01647607?

This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01647607's enrollment target sits among peer trials

467 222nd of 2000 higher than 1,779 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06456554 · 467 participants · NA

    Acellular Dermal Matrix Investigation in Breast Reconstruction

  • NCT03124303 · 468 participants

    Interventions for Postoperative Delirium: Biomarker-3

  • NCT03901924 · 468 participants · NA

    Volume Support/Assist Control Mode Ventilation and Diaphragmatic Atrophy

  • NCT04482309 · 468 participants · Phase 2

    A Phase 2 Study of T-DXd in Patients With Selected HER2 Expressing Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01647607, the US trial registry maintained by the National Library of Medicine. NCT01647607 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.